We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2023 Volume 3 Issue 2

Primary Squamous Cell Carcinoma of the Urinary Bladder: A Case Report and Comprehensive Literature Review


, , , ,
  1. Department of Pathology Dr. D.Y Patil Medical College, Hospital and Research Centre, Dr. D.Y Patil Vidyapeeth, Pimpri, Pune – 411018, India.

     
Abstract

Bladder cancer is a common malignancy of the urinary system, with transitional cell carcinoma (TCC) being the most common, accounting for the majority of cases (90-95%). This type of cancer typically affects people in their 60s and 70s, and men are affected significantly more often than women. Other types of bladder cancers, including epithelial and mesenchymal tumors, make up the remaining 5-10%. Squamous cell carcinoma (SCC) of the bladder is rare, contributing to only 1-3% of all bladder cancers. When only small amounts of squamous differentiation are present, the tumor is not categorized as SCC. SCC is often diagnosed at an advanced stage, leading to a poorer prognosis for patients. The main factor associated with the development of SCC is chronic irritation, often caused by conditions such as recurrent urinary infections, bladder stones, or schistosomiasis. In this report, we present a 70-year-old male patient who exhibited symptoms of blood in the urine, discomfort, and decreased urination frequency. A biopsy performed on the thickened bladder tissue confirmed the presence of well-differentiated SCC.


How to cite this article
Vancouver
Iqbal B, Kumar H, Vishwanathan V, Zaheer M, Gore C. Primary Squamous Cell Carcinoma of the Urinary Bladder: A Case Report and Comprehensive Literature Review. Asian J Curr Res Clin Cancer. 2023;3(2):15-8. https://doi.org/10.51847/FcXT9SREu1
APA
Iqbal, B., Kumar, H., Vishwanathan, V., Zaheer, M., & Gore, C. (2023). Primary Squamous Cell Carcinoma of the Urinary Bladder: A Case Report and Comprehensive Literature Review. Asian Journal of Current Research in Clinical Cancer, 3(2), 15-18. https://doi.org/10.51847/FcXT9SREu1

About GalaxyPub

Find out more

Galaxy Publication is an independent scholarly publishing platform operating under the scientific and organizational designation of Eshragh Scientific and Research Center and the legal framework of ISRAK PUBLISHER EGITIM HIZMETLERI LIMITED.

The publisher is committed to ethical, transparent, and high-quality academic publishing and supports scholarly communication through internationally aligned editorial practices, publication ethics, and responsible dissemination of scientific research.